Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
SOX9 expression
Cancer:
Triple Negative Breast Cancer
Drug:
JQ-1
(
BET inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
ESMO 2019
Title:
IDENTIFICATION OF A STEMNESS-RELATED GENE PANEL ASSOCIATED WITH BET INHIBITION IN TRIPLE NEGATIVE BREAST CANCER
Published date:
09/30/2019
Excerpt:
Four of the identified stemness genes, GJA1, CD24, EPCAM, and SOX9, were found to be associated with worse patient outcome in TNBC.
DOI:
10.1093/annonc/mdz268
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login